TY - JOUR
T1 - The association between chronic obstructive pulmonary disease and autoimmune diseases
T2 - a bidirectional Mendelian randomization study
AU - Yu, Xiaohui
AU - Cheng, Xue
AU - Lv, Lin
AU - Wang, Na
AU - Li, Mengcong
AU - Ji, Wenwen
AU - Liu, Tingting
AU - Wang, Guangdong
AU - Hu, Tinghua
AU - Shi, Zhihong
N1 - Publisher Copyright:
Copyright © 2024 Yu, Cheng, Lv, Wang, Li, Ji, Liu, Wang, Hu and Shi.
PY - 2024
Y1 - 2024
N2 - Objective: Observational studies have reported that chronic obstructive pulmonary disease (COPD) is often accompanied by autoimmune diseases, but the causal relationships between them remain uncertain. In this Mendelian study, we aimed to investigate the potential causal relationship between COPD and four common autoimmune diseases. Methods: We conducted an analysis of summary data on COPD and autoimmune disease using publicly available genome-wide association studies (GWAS) summary data. We initially employed the inverse- variance weighted method as the primary approach to establish the causal impact of COPD on autoimmune diseases in the sample and conducted additional sensitivity analyses to examine the robustness of the results. Subsequently, we performed reverse Mendelian randomization (MR) analyses for the four autoimmune diseases. Finally, the potential for bidirectional causal relationships was assessed. Results: Our MR analysis revealed no significant causal relationship between COPD and any of the studied autoimmune diseases. However, reverse MR results indicated a significant association between rheumatoid arthritis (RA), osteoarthritis (OA) and the risk of developing COPD, with respective odds ratios (OR) of 377.313 (95% CI, 6.625–21487.932, P = 0.004) for RA and 11.097 (95% CI, 1.583–77.796, P = 0.015) for OA. Sensitivity analyses confirmed the robustness of the results. Conclusion: Our findings support a potential causal relationship between autoimmune diseases and COPD, highlighting the importance of considering comorbidities in clinical management of COPD.
AB - Objective: Observational studies have reported that chronic obstructive pulmonary disease (COPD) is often accompanied by autoimmune diseases, but the causal relationships between them remain uncertain. In this Mendelian study, we aimed to investigate the potential causal relationship between COPD and four common autoimmune diseases. Methods: We conducted an analysis of summary data on COPD and autoimmune disease using publicly available genome-wide association studies (GWAS) summary data. We initially employed the inverse- variance weighted method as the primary approach to establish the causal impact of COPD on autoimmune diseases in the sample and conducted additional sensitivity analyses to examine the robustness of the results. Subsequently, we performed reverse Mendelian randomization (MR) analyses for the four autoimmune diseases. Finally, the potential for bidirectional causal relationships was assessed. Results: Our MR analysis revealed no significant causal relationship between COPD and any of the studied autoimmune diseases. However, reverse MR results indicated a significant association between rheumatoid arthritis (RA), osteoarthritis (OA) and the risk of developing COPD, with respective odds ratios (OR) of 377.313 (95% CI, 6.625–21487.932, P = 0.004) for RA and 11.097 (95% CI, 1.583–77.796, P = 0.015) for OA. Sensitivity analyses confirmed the robustness of the results. Conclusion: Our findings support a potential causal relationship between autoimmune diseases and COPD, highlighting the importance of considering comorbidities in clinical management of COPD.
KW - COPD
KW - Mendelian randomization
KW - autoimmune diseases
KW - causality
KW - genome-wide association study
UR - https://www.scopus.com/pages/publications/85188118513
U2 - 10.3389/fmed.2024.1331111
DO - 10.3389/fmed.2024.1331111
M3 - 文章
AN - SCOPUS:85188118513
SN - 2296-858X
VL - 11
JO - Frontiers in Medicine
JF - Frontiers in Medicine
M1 - 1331111
ER -